XML 72 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Stock Based Compensation
12 Months Ended
Dec. 31, 2012
Stock Based Compensation [Text Block]
9.

Stock-based Compensation

   
 

The Company adopted a Stock Option Plan dated November 7, 2005 under which the Company is authorized to grant stock options to acquire up to a total of 10,000,000 shares of common stock. No options shall be issued under the Stock Option Plan at a price per share less than the defined Market Price. On June 11, 2008, the Company modified the Stock Option Plan to define Market Price as the volume weighted average trading price of the Company’s common shares on the Toronto Stock Exchange or American Stock Exchange, now the NYSE Amex, whichever has the greater trading volume for the five trading days before the date of grant. On June 15, 2011, the Company amended the 2005 Non-Qualified Stock Option Plan to increase the number of shares authorized for issuance under the plan from 10,000,000 to 30,000,000 and extend the plan termination date for an additional 10 years.

   
 

On March 3, 2010, the Company modified the terms of 5,286,700 outstanding options. The weighted average grant date fair value of the modified stock options was $0.49 and the Company recognized an additional $2,535,808 stock-based compensation expense which is included in general and administrative expense related to the modification of these options.

   
 

During the year ended December 31, 2010, the Company granted 1,240,000 stock options to directors, officers, employees and consultants to acquire 702,500 common shares at an exercise price of $1.33 per share for 5 - 10 years, 185,000 common shares at an exercise price of $1.35 per share for 1.5 years, 100,000 common shares at an exercise price of $1.40 per share for 10 years, 200,000 common shares at an exercise price of $1.64 per share for 1.5 years, 2,500 common shares at an exercise price of $1.20 per share for 1.5 years, and 50,000 common shares at an exercise price of $3.19 per share for two years. During the year ended December 31, 2010, the Company recorded stock-based compensation for the vested options of $1,210,357 as general and administrative expense related to these options.

   
 

During the year ended December 31, 2011, the Company granted 2,624,500 stock options with immediate vesting to directors, officers, employees and consultants to acquire 1,045,000 common shares at an exercise price of $3.98 per share expiring in 5 – 10 years, 884,500 common shares at an exercise price of $3.21 per share for 10 years, 50,000 common shares at $2.87 per share for 2 years, and 645,000 common shares at an exercise price of $1.89 per share for 5 – 10 years. The Company also granted 802,500 stock options to acquire 802,500 shares at $1.89 per share for 10 years that vest 40% on the date of grant, 30% on the first anniversary of the grant date and 30% on the second anniversary of the grant date. During the year ended December 31, 2011, the Company recorded stock-based compensation for the vested options of $6,299,188, as general and administrative expense, $105,119 as exploration expenses.

   
 

During the year ended December 31, 2012, the Company recorded $315,502 for the vesting of previously granted stock options, as general and administrative expense.

   
 

During the year ended December 31, 2012, the Company granted 80,000 stock options with immediate vesting to consultants to acquire 80,000 common shares at an exercise price of $1.32 per share expiring in 2 – 10 years. The Company also granted 1,610,500 stock options to acquire 1,610,500 shares at $1.32 per share for 10 years that vest 40% on the date of grant, 30% on the first anniversary of the grant date and 30% on the second anniversary of the grant date. During the year ended December 31, 2012, the Company recorded stock-based compensation for the vested options of $685,683, as general and administrative expense, $203,584 as exploration expenses.

   
 

On October 3, 2012, the Company modified the terms of 767,700 outstanding options held by the Company’s former Executive Vice President. The options were set to expire on October 15, 2012 and the Company extended the expiration date to March 15, 2014. The weighted average grant date fair value of the modified stock options was $0.37 and the Company recognized an additional $243,625 stock-based compensation expense which is included in general and administrative expense related to the modification of these options.

   
 

The weighted average grant date fair value of stock options granted during the years ended December 31, 2012, 2011 and 2010 was $1.23, $2.05 and $0.93 per share, respectively. At December 31, 2012, the Company had 17,084,860 shares of common stock available to be issued under the Stock Option Plan.

   
 

The weighted average assumptions used for each of the years ended December 31, are as follows:


      2012     2011     2010  
                     
  Expected dividend yield   0%     0%     0%  
  Risk-free interest rate   1.72%     1.42%     1.57%  
  Expected volatility   119%     97%     107%  
  Expected option life (in years)   9.70     4.68     3.27  

 

   
 

The total intrinsic value of stock options exercised during the years ended December 31, 2012, 2011 and 2010, was $164,439, $6,849,524, and $1,003,198 respectively.

   
 

The following table summarizes the continuity of the Company’s stock options:


                  Weighted-        
            Weighted     Average        
            Average     Remaining     Aggregate  
      Number of     Exercise     Contractual     Intrinsic  
      Options     Price     Term (years)     Value  
                       
                           
  Outstanding, December 31, 2009   5,949,700     1.88              
                           
  Granted   1,240,000     1.46              
  Exercised   (454,100 )   0.95              
                           
  Outstanding, December 31, 2010   6,735,600     1.86              
                           
  Granted   3,427,000     2.88              
  Exercised   (2,223,920 )   1.01              
  Expired   (187,500 )   2.59              
                           
  Outstanding, December 31, 2011   7,751,180     2.54              
                           
  Granted   1,690,500     1.32              
  Exercised   (120,800 )   0.80              
  Expired   (95,000 )   3.13              
                           
  Outstanding, December 31, 2012   9,225,880     2.33     6.39     615,497  
                           
  Exercisable, December 31, 2012   8,018,830     2.47     5.92     547,856  

A summary of the status of the Company’s non-vested stock options outstanding as of December 31, 2012, and changes during the years ended December 31, 2012, 2011 and 2010 is presented below:

            Weighted  
            Average  
      Number of     Grant Date  
  Non-vested stock options   Options     Fair Value  
             
               
  Non-vested at December 31, 2009   127,000     1.33  
               
  Granted   1,240,000     0.93  
  Vested   (1,292,000 )   0.95  
               
  Non-vested at December 31, 2010   75,000     1.16  
               
  Granted   3,427,000     2.05  
  Vested   (3,020,500 )   2.13  
               
  Non-vested at December 31, 2011   481,500     1.37  
               
  Granted   1,690,500     1.23  
  Vested   (964,950 )   1.20  
               
  Non-vested at December 31, 2012   1,207,050     1.24  

As at December 31, 2012, there was $1,534,945 of unrecognized compensation cost related to non-vested stock option agreements. This cost is expected to be recognized over a weighted average period of 1.76 years.